New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2012
16:30 EDTTELKTelik publishes clinical trial abstract on ICN treatment
This abstract reports the preliminary results of a clinical trial with ezatiostat to study the treatment of patients with idiopathic chronic neutropenia, ICN. ICN is a rare group of blood disorders characterized by low circulating neutrophils, recurrent fevers, mucosal inflammation and serious systemic infections. The risk and severity of these complications is related to abnormally low levels of white blood cells. Most patients initially respond to treatment with granulocyte colony stimulating factors, G-CSF; however, some patients fail to respond or become resistant to G-CSF treatments. Further, G-CSF therapy is often associated with bone and muscle pain, low platelet counts and enlargement of the spleen. Patients may need to be on G-CSF for the rest of their lives, and these side effects can interfere with therapy.
News For TELK From The Last 14 Days
Check below for free stories on TELK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 25, 2014
09:31 EDTTELKTelik receives $1.5M contract
Subscribe for More Information
August 15, 2014
08:15 EDTTELKTelik to hold a special shareholder meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use